Profile data is unavailable for this security.
About the company
Microbix Biosystems Inc. is a Canada-based company. The Company develops and commercializes proprietary biological and technology solutions for human health and wellbeing. It manufactures a range of critical biological materials and medical devices for the global diagnostics industry, notably test ingredients (Antigen business) used in immunoassays, quality assessment and proficiency testing controls (QAPsTM business), and sample collection devices (DxTMTM business). The Company operates in two ways: (i) the development, manufacturing, and sale of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples, and (ii) the development and commercialization of novel and proprietary products or technologies such as Kinlytic. It's Kinlytic Urokinase, a biologic thrombolytic drug used to treat blood clots.
- Revenue in CAD (TTM)18.59m
- Net income in CAD-2.25m
- Incorporated1978
- Employees69.00
- LocationMicrobix Biosystems Inc265 Watline AvenueMISSISSAUGA L4Z 1P3CanadaCAN
- Phone+1 (905) 361-8910
- Fax+1 (905) 361-8910
- Websitehttps://microbix.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Neurothera Labs Inc | 0.00 | -209.09k | 15.71m | -- | -- | 3.76 | -- | -- | -0.0116 | -0.0116 | 0.00 | 0.0493 | 0.00 | -- | -- | -- | -19.28 | -- | -21.28 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -143.95 | -- | -- | -- |
| Sirona Biochem Corp | -16.37k | -2.67m | 15.82m | -- | -- | -- | -- | -- | -0.0105 | -0.0105 | -0.00006 | -0.0134 | -0.0171 | -- | 1.61 | -- | -278.90 | -173.09 | -- | -383.49 | -- | -- | -- | -1,405.28 | -- | -5.73 | -- | -- | -94.82 | -51.37 | 28.52 | -- | -- | -- |
| Numinus Wellness Inc | 5.33m | -10.67m | 16.32m | 35.00 | -- | -- | -- | 3.06 | -0.0366 | -0.0481 | 0.0175 | -0.0049 | 0.5827 | -- | 3.41 | -- | -116.67 | -77.90 | -231.32 | -88.05 | 44.96 | 31.24 | -200.23 | -325.94 | -- | -- | 3.02 | -- | -82.02 | -- | 51.75 | -- | -- | -- |
| Hemostemix Inc | 0.00 | -3.40m | 17.57m | -- | -- | -- | -- | -- | -0.03 | -0.03 | 0.00 | -0.0188 | 0.00 | -- | -- | -- | -453.77 | -579.31 | -- | -- | -- | -- | -- | -- | -- | -6.01 | -- | -- | -- | -- | -4.57 | -- | -- | -- |
| Avicanna Inc | 25.50m | -1.88m | 21.37m | 38.00 | -- | 6.44 | -- | 0.838 | -0.0165 | -0.0165 | 0.2262 | 0.0264 | 1.22 | 2.89 | 10.84 | -- | -9.02 | -61.54 | -51.98 | -226.72 | 51.95 | 49.33 | -7.37 | -150.05 | 0.3804 | -- | 0.00 | -- | 51.62 | 172.88 | 58.62 | -- | -44.27 | -- |
| Resverlogix Corp | 0.00 | -9.66m | 27.33m | 18.00 | -- | -- | -- | -- | -0.034 | -0.034 | 0.00 | -0.4218 | 0.00 | -- | -- | 0.00 | -91.25 | -- | -- | -- | -- | -- | -- | -- | 0.0248 | -1.30 | -- | -- | -- | -- | 54.39 | -- | -- | -- |
| Thiogenesis Therapeutics Corp | 0.00 | -6.82m | 28.51m | -- | -- | 13.24 | -- | -- | -0.1439 | -0.1439 | 0.00 | 0.0415 | 0.00 | -- | -- | -- | -173.15 | -- | -216.52 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 37.87 | -- | -- | -- |
| Principal Technologies Inc | 262.84k | -4.32m | 29.19m | -- | -- | -- | -- | 111.07 | -0.1043 | -0.1072 | 0.0063 | -0.0126 | 0.2272 | -- | 1.68 | -- | -372.16 | -- | -2,615.25 | -- | -- | -- | -1,637.81 | -- | -- | -223.78 | -- | -- | -44.22 | -- | -162.24 | -- | -- | -- |
| Microbix Biosystems Inc | 18.59m | -2.25m | 30.48m | 69.00 | -- | 1.10 | -- | 1.64 | -0.0161 | -0.0161 | 0.1344 | 0.1992 | 0.4923 | 1.12 | 6.44 | -- | -5.95 | 3.86 | -6.48 | 4.37 | 53.02 | 55.92 | -12.08 | 6.37 | 5.17 | -2.23 | 0.196 | -- | -26.81 | 12.04 | -163.80 | -- | -0.4115 | -- |
| MustGrow Biologics Corp | 7.54m | -6.37m | 38.34m | 0.00 | -- | 12.34 | -- | 5.09 | -0.1206 | -0.1206 | 0.1435 | 0.0494 | 1.45 | 5.49 | 45.16 | -- | -122.84 | -54.87 | -193.93 | -66.95 | 14.51 | -- | -84.52 | -341.26 | 1.25 | -103.31 | 0.1671 | -- | -91.55 | -- | -622.18 | -- | -- | -- |
| Briacell Therapeutics Corp | 0.00 | -39.09m | 39.91m | 22.00 | -- | 0.7632 | -- | -- | -72.56 | -72.56 | 0.00 | 7.21 | 0.00 | -- | -- | 0.00 | -246.96 | -63.88 | -359.42 | -70.71 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -449.14 | -- | -- | -- |
| Holder | Shares | % Held |
|---|---|---|
| Next Edge Capital Corp.as of 30 Jun 2024 | 586.50k | 0.42% |
